SWOBY vs ABBV: Which Stock is Better?

Side-by-side comparison of Swedish Orphan Biovitrum AB (publ) and Abbvie Inc in 2026

Comparison Updated:

SWOBY

Swedish Orphan Biovitrum AB (publ)

$19.63

ABBV

Abbvie Inc

$208.99

Key Metrics Comparison

MetricSWOBYABBVWinner
Market Cap$14.20B$368.65BABBV
P/E Ratio280.3987.57ABBV
EPS (TTM)$0.07$2.38ABBV
Revenue Growth0.1%0.1%ABBV
Gross Margin78.2%71.6%SWOBY

Analyze SWOBY

Full quant analysis

Analyze ABBV

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is SWOBY or ABBV a better investment?

Comparing SWOBY and ABBV: Swedish Orphan Biovitrum AB (publ) has a market cap of $14.20B while Abbvie Inc has $368.65B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between SWOBY and ABBV?

SWOBY (Swedish Orphan Biovitrum AB (publ)) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: SWOBY or ABBV?

Based on P/E ratios, ABBV trades at a lower multiple (87.6x vs 280.4x).

Which is growing faster: SWOBY or ABBV?

ABBV has higher revenue growth at 0.1% vs 0.1% for SWOBY.

Which company is more profitable: SWOBY or ABBV?

Swedish Orphan Biovitrum AB (publ) (SWOBY) has higher gross margins at 78.2% compared to 71.6% for ABBV.

Which is the larger company: SWOBY or ABBV?

Abbvie Inc (ABBV) is larger with a market cap of $368.65B compared to $14.20B for SWOBY.

Should I buy SWOBY or ABBV in 2026?

Both SWOBY and ABBV have investment merit. SWOBY trades at $19.63 while ABBV trades at $208.99. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between SWOBY and ABBV stock?

Key differences: Market Cap ($14.20B vs $368.65B), P/E Ratio (280.4x vs 87.6x), Revenue Growth (0.1% vs 0.1%), Gross Margin (78.2% vs 71.6%).

Popular Stock Comparisons